Immuno-Oncology — Forum MedTech Pharma e.V.

Conference with accompanying exhibition
Technologies for Immuno-Oncology

Wednesday, April 3, 2019

9:30 - 18:00

Venue:
TranslaTUM - Center for Translational Cancer Research, Einsteinstraße 25, 81675 Munich

The event is presented in cooperation with TranslaTUM – Center for Translational Cancer Research, and Bio^M Biotech Cluster Development GmbH.

The event is sponsored by Bristol-Myers Squibb.

Brochure of the event

Registration: Please register via our Online-Shop

Exhibitors:

• Biovariance GmbH • Bristol-Myers Squibb GmbH & Co. KGaA • Cenibra GmbH • Dynamic Biosensors GmbH • Eurofins Genomics Europe Shared Services GmbH • HOT Screen GmbH • Miltenyi Biotec GmbH • Ovizio Imaging Systems NV/SA • PromoCell GmbH • Sartorius Lab Instruments GmbH & Co. KG

Exhibition: Registration for exhibitors

Participation Fee: Members of Forum MedTech Pharma e.V.: 160 €, Non-members Research & Clinics: 240 €,
Non-members Industry 320 €
(plus VAT 7%)

Concept and Organisation: Forum MedTech Pharma e.V.

Contact Person: Dr. Monika Mügschl-Scharf (muegschl@medtech-pharma.de)

Cancellations received before March 27, 2019 are exempt from charges. For later cancellations and for non-attendance, the full amount will be incurred. Your address data is only used internally by Forum MedTech Pharma e.V.

Topic

Immunotherapies against cancer open up completely new opportunities to fight this “emperor of all maladies“. But for this kind of therapies to become widely applied and successful, technological hurdles have yet to be overcome.

For one, meaningful biomarkers must be identified, for patient stratification as well as for monitoring therapeutic success. On the other hand, some immuno-therapeutics are not the usual kind of drugs. They are so-called Advanced Therapy Medicinal Products (ATMPs), and their production, quality & security control and delivery to the patient are especially challenging.

At the Conference “Technologies for Immuno-Oncology“, researchers, clinicians and companies will show approaches to tackle those challenges. The importance of translational research in unleashing the potential of those novel strategies to fight cancer will be highlighted.

In the afternoon of the conference day, attendees will have the opportunity to visit the research facilities at the TranslaTUM - Center for Translational Cancer Research, including the Core Facilities Imaging, Preclinical Research and Cell Analysis. TranslaTUM staff will be available for Q&As by the participants during a “Meet the Scientists” session. Company demonstrators as well as an accompanying exhibition will showcase technological innovations for immuno-oncology.

Images: fotolia/DesignCells, fotolia/sommart, TranslaTUM

Zeit	Referent	Titel
from 8:30 Registration & Welcome Coffee
09:30	Dr. Monika Mügschl-Scharf Forum MedTech Pharma e.V., Nürnberg Prof. Dr. Oliver Hayden TranslaTUM - Center for Translational Cancer Research, Munich	Welcome (only for participants and members, PDF 1.1 MB) Welcome TranslaTUM (only for participants and members, PDF 1.1 MB)
10:00	Prof. Dr. med. Jürgen Ruland Department of Clinical Chemistry, Technische Universität München	KEYNOTE: Immune Signals in Cancer
Biomarkers for Immuno-Oncology
10:30	Prof. Dr. Wolfgang Weber Department of Nuclear Medicine, Klinikum rechts der Isar, Munich	PET Imaging in Immunotherapy
10:55	Dr. Holger Krönig Medical Director Oncology, Bristol-Myers Squibb GmbH & Co. KGaA, Munich	KEYNOTE: Biomarkers for Immuno-Oncology
11:25 - 12:00 Coffee Break
Cell Engineering & Analysis
12:00	Dr. Ram Shankar Manager R&D, PlasmidFactory GmbH & Co. KG, Bielefeld	Minicircle DNA – New Tool for Cell Therapy (download only for participants and members, PDF 1 MB)
12:25	Prof. Dr. med. Dirk Busch Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München	Engineering of T-Cells for Adoptive Immunotherapy (download only for participants and members, PDF 14.3 MB)
12:50	• Progressing 3D Spheroid Analysis into a HTS Drug Discovery Method, Dr. Illip Burmester, Cenibra GmbH, Bramsche • Binding analysis of bispecific antibodies for targeted tumor engagement, Dr. Ulrich Rant, Dynamic Biosensors GmbH, Martinsried • The DNA Universe - Genomic Services for Your Clinical Studies and Research, Dr. Bernhard Busch, Eurofins Genomics Germany GmbH, Ebersberg • Organotypical profiling of Checkpoint Inhibitors Using Human High-End Whole Blood Culture Models, Dr. Manfred Schmolz, HOT Screen GmbH, Reutlingen • Label-free and In-line CAR-T Monitoring in Bioreactor, Emilie Viey / Serge Jooris, Ovizio Imaging Systems NV/SA, Brussels (BEL) • Innovative Solutions for Cell Culture Research and Cell Line Development, Marlene Posch-Devedzic, Sartorius Lab Instruments GmbH & Co. KG, Göttingen	Exhibitor Pitch Session: Technologies for Immuno-Oncology Dynamic Biosensors GmbH Eurofins Genomics Europe Shared Services GmbH HOT Screen GmbH Ovizio Imaging Systems NV/SA Sartorius Lab Instruments GmbH & Co. KG (download only for participants and members, PDF 0.6 MB)
13:15 - 14:15 Lunch Break
Cell Production & Realisation of Therapies
14:15	Dr. Klaus Kühlcke Managing Director, BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein
14:40	Dr. Andrew Kaiser R&D Manager Immunotherapy and Gene-Engineering, Miltenyi Biotec GmbH, Bergisch Gladbach	A Cell Factory and Automated Manufacturing Platforms Serving Cellular Therapies (download only for participants and members, PDF 4.9 MB)
15:05	Dr. Tobias Ostler Associate Director Regulatory Compliance, SYNLAB Analytics & Services Switzerland AG, Birsfelden (CH)	ATMP Development: the Expectations of the Regulatory Agencies (download only for participants and members, PDF 0.5 MB)
15:30 - 16:00 Coffee Break
16:00	Dr. Niklas Münchmeier Medical Manager Cell & Gene Therapy, Novartis Pharma GmbH, Nuremberg	KEYNOTE: CAR-T Cell Immunotherapy in Leukemias and Lymphomas – From Research to Market
Interaction time (16:30 – 17:15 in parallel - your options) • Company Demonstrators: o Cenibra GmbH, Bramsche o Miltenyi Biotec GmbH, Bergisch Gladbach o Ovizio Imaging Systems NV/SA, Brussels (BEL) • Visit of TranslaTUM Research Facilities • Meet-the-Scientists
17:15	Wrap-Up & Closing Remarks
from 17:30 Get-together

Forum MedTech Pharma Netzwerk für Innovationen

KEYNOTE: Immune Signals in Cancer

Biomarkers for Immuno-Oncology

PET Imaging in Immunotherapy

KEYNOTE: Biomarkers for Immuno-Oncology

11:25 - 12:00 Coffee Break

Cell Engineering & Analysis

Exhibitor Pitch Session: Technologies for Immuno-Oncology

13:15 - 14:15 Lunch Break

Cell Production & Realisation of Therapies

15:30 - 16:00 Coffee Break

KEYNOTE: CAR-T Cell Immunotherapy in Leukemias and Lymphomas – From Research to Market

Interaction time (16:30 – 17:15 in parallel - your options)

• Company Demonstrators:

• Visit of TranslaTUM Research Facilities

• Meet-the-Scientists

Wrap-Up & Closing Remarks

from 17:30 Get-together

Exhibitor Pitch Session:
Technologies for Immuno-Oncology